# BeiGene

> Developing affordable cancer treatments

Business model and tags: B2B, Has physical offices, Publicly traded, Manufacturing, Multi-product, Pharma & life sciences, Multi-site, International operations, Has production sites, Has in-house R&D, Has field sales reps, Has a works council, Handles regulated data

## About BeiGene

Global oncology company developing accessible and affordable cancer treatments through innovative research, collaborations, and commitment to improving medicine access for patients worldwide

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Cambridge, Massachusetts, United States
- **Founded**: 2010
- **Revenue**: $5.3B (FY2025, publicly reported)
- **Website**: [beonemedicines.com](https://beonemedicines.com/)
- **LinkedIn**: [linkedin.com/company/beigene](https://www.linkedin.com/company/beigene)

## BeiGene at a glance

BeiGene is a B2B company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, United States.

BeiGene was founded in 2010.

BeiGene has 1,001–5,000 employees.

BeiGene's revenue is $5.3B (FY2025, publicly reported).

## Frequently asked questions about BeiGene

### What is BeiGene's revenue?

BeiGene's revenue is $5.3B (FY2025, publicly reported).

### How many employees does BeiGene have?

BeiGene has 1,001–5,000 employees.

### Where is BeiGene headquartered?

BeiGene is headquartered in Cambridge, Massachusetts, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/beigene
